We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RKDA market cap is 6.47M. The company's latest EPS is USD -10.2429 and P/E is -0.46.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.26M | 1.17M | 1.26M | 1.04M | 1.54M |
| Operating Income | -2.74M | -3.37M | -3.06M | -546k | -1.76M |
| Net Income | -2.57M | -2.85M | -2.42M | 1.06M | -1.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.17M | 8.03M | 6.78M | 9.96M | 5.33M |
| Operating Income | -19.38M | -21.59M | -35.24M | -20.34M | -13.98M |
| Net Income | -28.81M | -4.66M | -14.66M | -15.38M | -13.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.47M | 19.71M | 16.05M | 17.37M | 15.24M |
| Total Liabilities | 8.07M | 7M | 5.56M | 5.8M | 5.09M |
| Total Equity | 15.4M | 12.7M | 10.48M | 11.57M | 10.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 32.57M | 47.35M | 43.92M | 28.92M | 19.71M |
| Total Liabilities | 24.25M | 18.8M | 12.72M | 8.02M | 7M |
| Total Equity | 8.33M | 28.55M | 31.2M | 20.9M | 12.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.15M | -15.29M | -3.21M | -5.67M | -7.42M |
| Investing | -4.4M | -4.34M | 4k | 4.65M | 4.83M |
| Financing | 5.51M | 5.51M | 5k | 5k | 9k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.2M | -30.22M | -25.87M | -13.98M | -15.29M |
| Investing | -8.37M | 17.28M | 16.61M | 1.42M | -4.34M |
| Financing | 21.99M | 20.56M | 21.9M | 4.52M | 5.51M |
| Market Cap | 6.47M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 1.21 |
| Price to Cash Ratio | 0.99 |
| Price to Book Ratio | 0.51 |
| Dividend Yield | - |
| Shares Outstanding | 1.36M |
| Average Volume (1 week) | 5.87k |
| Average Volume (1 Month) | 6.69k |
| 52 Week Change | 83.01% |
| 52 Week High | 10.3099 |
| 52 Week Low | 1.8512 |
| Spread (Intraday) | 0.26 (5.27%) |
| Company Name | Arcadia Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.arcadiabio.com |
| Industry | pesticides, agric chems, nec (2879) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
